BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 10754415)

  • 21. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
    Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
    J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of quantitative-PCR versus serology for detection of CMV in pre- and post- transplantation patients.
    Al-Attas SG; Shehata MI; Esmaeal HM; Radhwan NA
    Egypt J Immunol; 2010; 17(1):41-8. PubMed ID: 22053608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of the predictive value of polymerase chain reaction assay for cytomegalovirus in asymptomatic kidney transplant recipients.
    Benedetti E; Mihalov M; Asolati M; Kirby J; Dunn T; Raofi V; Fontaine M; Pollak R
    Clin Transplant; 1998 Oct; 12(5):391-5. PubMed ID: 9787946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of antibody response to human cytomegalovirus in Indian renal transplant patients.
    Finny GJ; Rao M; Mach M; Juneja R; Thomas PP; Jacob CK; Manayani DJ; Abraham P; Abraham M; Sridharan G
    Indian J Med Res; 2001 Jun; 113():221-7. PubMed ID: 11816956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of oral cytomegalovirus DNA shedding for the prediction of viral DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Pascual T; Solano C; Torres I; Talaya A; Giménez E; Vinuesa V; Piñana JL; Hernández-Boluda JC; Pérez A; Navarro D
    J Med Virol; 2018 Aug; 90(8):1375-1382. PubMed ID: 29663435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High human cytomegalovirus DNAemia early post-transplantation associates with irreversible and progressive loss of renal function - a retrospective study.
    Lollinga WT; Rurenga-Gard L; van Doesum W; van Bergen R; Diepstra A; Vonk JM; Riezebos-Brilman A; Niesters HGM; van Son WJ; van den Born J; Sanders JS
    Transpl Int; 2017 Aug; 30(8):817-826. PubMed ID: 28432714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymerase chain reaction as a rapid diagnostic assay for cytomegalovirus infection in renal transplant patients.
    Lisby G; Dessau RB; Andersen CB; Ladefoged S
    APMIS; 1994 Sep; 102(9):690-4. PubMed ID: 7946272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring human cytomegalovirus viral load in peripheral blood leukocytes of renal transplant recipients by a simple limiting dilution-PCR assay.
    Caballero OL; Costa MC; Trevisan A; Oliveira RM; Viotti EA; Távora ER; Vilaça SS; Sabagga E; De-Paula FJ; Távora PF; Brasileiro-Filho G; Villa LL; Simpson AJ
    Braz J Med Biol Res; 1999 Dec; 32(12):1515-23. PubMed ID: 10585633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.
    Elfadawy N; Flechner SM; Liu X; Schold J; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Transplantation; 2013 Dec; 96(12):1097-103. PubMed ID: 24056621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
    Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
    J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between the detection of viral DNA by the polymerase chain reaction in peripheral blood leukocytes and serological responses to human herpesvirus 6, human herpesvirus 7, and cytomegalovirus in renal allograft recipients.
    Osman HK; Peiris JS; Taylor CE; Karlberg JP; Madeley CR
    J Med Virol; 1997 Nov; 53(3):288-94. PubMed ID: 9365898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid detection of cytomegalovirus DNA in sera using the polymerase chain reaction: relationship with clinical diagnosis of cytomegalovirus infection after renal transplantation.
    Yamamoto T; Nakajima Y; Hironaka T; Hirai K; Nakamura Y
    Nephron; 1995; 70(1):100-3. PubMed ID: 7617086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.
    Pouteil-Noble C; Ecochard R; Bosshard S; Lacavalerie B; Donia A; Landrivon G; Tardy JC; Dubernard JM; Aymard M; Touraine JL
    Transpl Int; 1992; 5 Suppl 1():S26-9. PubMed ID: 14621724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation.
    Reischig T; Kacer M; Hruba P; Jindra P; Hes O; Lysak D; Bouda M; Viklicky O
    Antivir Ther; 2017; 22(6):503-513. PubMed ID: 28091392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid progression of HIV disease in children with cytomegalovirus DNAemia.
    Nigro G; Krzysztofiak A; Gattinara GC; Mango T; Mazzocco M; Porcaro MA; Provvedi S; Booth JC
    AIDS; 1996 Sep; 10(10):1127-33. PubMed ID: 8874630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic markers and risk factors of cytomegalovirus infection and disease in renal allograft recipients.
    Hökeberg I; Eriksson BM; Zweygberg-Wirgart B; Tufvesson G; Olding-Stenkvist E; Grillner L
    Scand J Infect Dis; 1995; 27(5):435-40. PubMed ID: 8588130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation.
    Boriskin YS; Fuller K; Powles RL; Vipond IB; Rice PS; Booth JC; Caul EO; Butcher PD
    J Clin Virol; 2002 Feb; 24(1-2):13-23. PubMed ID: 11744424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab.
    Jain T; John J; Kotecha A; Deol A; Saliminia T; Revankar S; Chandrasekar P
    Ann Hematol; 2016 Aug; 95(8):1323-7. PubMed ID: 27225264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.